TickerFactsScreenerDevelopers

Viking Therapeutics, Inc. (VKTX) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2013: -$250.6K2014: -$22.13M2015: $8.72M2016: $8.04M2017: $13.46M2018: $297.75M2019: $277.12M2020: $244.34M2021: $201.88M2022: $145.32M2023: $348.42M2024: $880.28M2025: $639.06M$639.06M
2013Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$639.06M-27.4%
2024$880.28M+152.6%
2023$348.42M+139.8%
2022$145.32M-28.0%
2021$201.88M-17.4%
2020$244.34M-11.8%
2019$277.12M-6.9%
2018$297.75M+2111.5%
2017$13.46M+67.4%
2016$8.04M-7.8%
2015$8.72M+139.4%
2014-$22.13M-8730.1%
2013-$250.6K—